TatorCH, FehlingsMG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg, 1991; 75(1):15–26; doi: 10.3171/jns.1991.75.1.0015.
2.
BadhiwalaJH, WilsonJR, WitiwCD, et al.The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data. Lancet Neurol, 2021; 20(2):117–126; doi: 10.1016/S1474-4422(20)30406-3.
3.
WaltersBC, HadleyMN, HurlbertRJ, et al.Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 Update. Neurosurgery, 2013; 60(CN_suppl_1):82–91; doi: 10.1227/01.neu.0000430319.32247.7f.
4.
FehlingsMG, WilsonJR, TetreaultLA, et al.A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate. Global Spine J, 2017; 7(3 Suppl):203S-211S; doi: 10.1177/2192568217703085.
HejratiN, FehlingsMG. A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury. Curr Opin Pharmacol, 2021; 60:331–340; doi: 10.1016/j.coph.2021.08.009.
7.
KangY, DingH, ZhouH, et al. Epidemiology of worldwide spinal cord injury: a literature review. J Neurorestoratol 2017;Volume 6:1–9; doi: 10.2147/JN.S143236.
8.
SinghA, TetreaultL, Kalsi-RyanS, et al.Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol, 2014; 6:309–331; doi: 10.2147/CLEP.S68889.
9.
AarabiB, AlexanderM, MirvisSE, et al.Predictors of outcome in acute traumatic central cord syndrome due to spinal stenosis: clinical article. J Neurosurg Spine, 2011; 14(1):122–130; doi: 10.3171/2010.9.SPINE09922.
10.
LenehanB, FisherCG, VaccaroA, et al.The urgency of surgical decompression in acute central cord injuries with spondylosis and without instability. Spine, 2010; 35(21S):S180; doi: 10.1097/BRS.0b013e3181f32a44.
11.
JainNB, AyersGD, PetersonEN, et al.Traumatic spinal cord injury in the United States, 1993-2012. JAMA, 2015; 313(22):2236–2243; doi: 10.1001/jama.2015.6250.
12.
Montoto-MarquésA, Ferreiro-VelascoME, Salvador-de la BarreraS, et al.Epidemiology of traumatic spinal cord injury in Galicia, Spain: trends over a 20-year period. Spinal Cord, 2017; 55(6):588–594; doi: 10.1038/sc.2017.13.
13.
ChenY, HeY, DeVivoMJ. Changing demographics and injury profile of new traumatic spinal cord injuries in the United States, 1972-2014. Arch Phys Med Rehabil, 2016; 97(10):1610–1619; doi: 10.1016/j.apmr.2016.03.017.
14.
AarabiB, AlbrechtJS, SimardJM, et al.Trends in demographics and markers of injury severity in traumatic cervical spinal cord injury. J Neurotrauma, 2021; 38(6):756–764; doi: 10.1089/neu.2020.7415.
15.
FurlanJC, FehlingsMG. The impact of age on mortality, impairment, and disability among adults with acute traumatic spinal cord injury. J Neurotrauma, 2009; 26(10):1707–1717; doi: 10.1089/neu.2009.0888.
16.
FurlanJC, KattailD, FehlingsMG. The impact of co-morbidities on age-related differences in mortality after acute traumatic spinal cord injury. J Neurotrauma, 2009; 26(8):1361–1367; doi: 10.1089/neu.2008.0764.
17.
KrassioukovAV, FurlanJC, FehlingsMG. Medical co-morbidities, secondary complications, and mortality in elderly with acute spinal cord injury. J Neurotrauma, 2003; 20(4):391–399; doi: 10.1089/089771503765172345.
18.
ShadganB, MacnabA, FongA, et al.Optical assessment of spinal cord tissue oxygenation using a miniaturized near infrared spectroscopy sensor. J Neurotrauma, 2019; 36(21):3034–3043; doi: 10.1089/neu.2018.6208.
19.
MartirosyanNL, KalaniMYS, BichardWD, et al.Cerebrospinal fluid drainage and induced hypertension improve spinal cord perfusion after acute spinal cord injury in pigs. Neurosurgery, 2015; 76(4):461–469; doi: 10.1227/NEU.0000000000000638.
20.
BadhiwalaJH, WilsonJR, WitiwCD, et al.The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data. Lancet Neurol, 2021; 20(2):117–126; doi: 10.1016/S1474-4422(20)30406-3.
21.
FehlingsMG, WilsonJR, TetreaultLA, et al.A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate. Global Spine J, 2017; 7(3 Suppl):203S-211S; doi: 10.1177/2192568217703085.
22.
PhangI, WerndleMC, SaadounS, et al.Expansion duroplasty improves intraspinal pressure, spinal cord perfusion pressure, and vascular pressure reactivity index in patients with traumatic spinal cord injury: injured spinal cord pressure evaluation study. J Neurotrauma, 2015; 32(12):865–874; doi: 10.1089/neu.2014.3668.
23.
FarhadiHF, KukrejaS, MinnemaA, et al.impact of admission imaging findings on neurological outcomes in Acute cervical traumatic spinal cord injury. J Neurotrauma, 2018; 35(12):1398–1406; doi: 10.1089/neu.2017.5510.
24.
MartirosyanNL, KalaniMYS, BichardWD, et al. Cerebrospinal fluid drainage and induced hypertension improve spinal cord perfusion after acute spinal cord injury in pigs. Neurosurgery 2015;76(4):461–468; discussion 468-469; doi: 10.1227/NEU.0000000000000638.
25.
SquairJW, BélangerLM, TsangA, et al.Empirical targets for acute hemodynamic management of individuals with spinal cord injury. Neurology, 2019; 93(12):e1205–e1211; doi: 10.1212/WNL.0000000000008125.
26.
LoTP, ChoKS, GargMS, et al.Systemic hypothermia improves histological and functional outcome after cervical spinal cord contusion in rats. J Comp Neurol, 2009; 514(5):433–448; doi: 10.1002/cne.22014.
27.
LeviAD, CasellaG, GreenBA, et al.Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. Neurosurgery, 2010; 66(4):670–677; doi: 10.1227/01.NEU.0000367557.77973.5F.
28.
FehlingsMG, WilsonJR, FrankowskiRF, et al.Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN phase I clinical trial. J Neurosurg Spine, 2012; 17(1 Suppl):151–156; doi: 10.3171/2012.4.AOSPINE1259.
29.
GrossmanRG, FehlingsMG, FrankowskiRF, et al.A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma, 2014; 31(3):239–255; doi: 10.1089/neu.2013.2969.
30.
ChioJCT, WangJ, BadnerA, et al. The effects of human Immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit. J Neuroinflammation 2019;16; doi: 10.1186/s12974-019-1518-0.
31.
ChioJCT, WangJ, SurendranV, et al.Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier. Neurobiol Dis, 2021; 148:105187; doi: 10.1016/j.nbd.2020.105187.
32.
WellsJEA, HurlbertRJ, FehlingsMG, et al.Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain, 2003; 126(7):1628–1637; doi: 10.1093/brain/awg178.
33.
StirlingDP, KhodarahmiK, LiuJ, et al.Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci, 2004; 24(9):2182–2190; doi: 10.1523/JNEUROSCI.5275-03.2004.
34.
CashaS, ZygunD, McGowanMD, et al.Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain, 2012; 135(4):1224–1236; doi: 10.1093/brain/aws072.
35.
SquairJW, RuizI, PhillipsAA, et al.Minocycline reduces the severity of autonomic dysreflexia after experimental spinal cord injury. J Neurotrauma, 2018; 35(24):2861–2871; doi: 10.1089/neu.2018.5703.
36.
KodaM, NishioY, KamadaT, et al.Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice. Brain Res, 2007; 1149:223–231; doi: 10.1016/j.brainres.2007.02.058.
37.
NishioY, KodaM, KamadaT, et al.Granulocyte colony-stimulating factor attenuates neuronal death and promotes functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol, 2007; 66(8):724–731; doi: 10.1097/nen.0b013e3181257176.
38.
DerakhshanradN, SaberiH, YekaninejadMS, et al.Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial. J Neurosurg Spine, 2018; 29(1):97–107; doi: 10.3171/2017.11.SPINE17769.
39.
KodaM, HanaokaH, SatoT, et al.Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury. BMJ Open, 2018; 8(5):e019083; doi: 10.1136/bmjopen-2017-019083.
40.
SalewskiRP, MitchellRA, LiL, et al.Transplantation of induced pluripotent stem cell-derived neural stem cells mediate functional recovery following thoracic spinal cord injury through remyelination of axons. Stem Cells Transl Med, 2015; 4(7):743–754; doi: 10.5966/sctm.2014-0236.
41.
LeviAD, AndersonKD, OkonkwoDO, et al.Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma, 2018; 36(6):891–902; doi: 10.1089/neu.2018.5843.
42.
CurtA, HsiehJ, SchubertM, et al.The damaged spinal Cord Is a Suitable Target for Stem Cell Transplantation. Neurorehabil Neural Repair, 2020; 34(8):758–768; doi: 10.1177/1545968320935815.
43.
BregmanBS, Kunkel-BagdenE, SchnellL, et al.Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature, 1995; 378(6556):498–501; doi: 10.1038/378498a0.
44.
FreundP, WannierT, SchmidlinE, et al.Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J Comp Neurol, 2007; 502(4):644–659; doi: 10.1002/cne.21321.
45.
KucherK, JohnsD, MaierD, et al.First-in-man intrathecal application of neurite growth-promoting Anti-Nogo-A antibodies in acute spinal cord injury. Neurorehabil Neural Repair, 2018; 32(6–7):578–589; doi: 10.1177/1545968318776371.
46.
Lord-FontaineS, YangF, DiepQ, et al.Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury. J Neurotrauma, 2008; 25(11):1309–1322; doi: 10.1089/neu.2008.0613.
47.
FehlingsMG, TheodoreN, HarropJ, et al.Phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J Neurotrauma, 2011; 28(5):787–796; doi: 10.1089/neu.2011.1765.
48.
FehlingsMG, ChenY, AarabiB, et al. A randomized controlled trial of local delivery of a Rho-inhibitor (VX-210) in patients with acute traumatic cervical spinal cord injury. J Neurotrauma 2021; doi: 10.1089/neu.2020.7096.
49.
MotheAJ, CoelhoM, HuangL, et al.Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats. Neurobiol Dis, 2020; 143:104995; doi: 10.1016/j.nbd.2020.104995.
50.
NakagawaH, NinomiyaT, YamashitaT, et al.Treatment with the neutralizing antibody against repulsive guidance molecule-a promotes recovery from impaired manual dexterity in a primate model of spinal cord injury. Cerebral Cortex, 2019; 29(2):561–572; doi: 10.1093/cercor/bhx338.
51.
BradburyEJ, MoonLDF, PopatRJ, et al.Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature, 2002; 416(6881):636–640; doi: 10.1038/416636a.
52.
NoriS, KhazaeiM, AhujaCS, et al.Human oligodendrogenic neural progenitor cells delivered with chondroitinase ABC facilitate functional repair of chronic spinal cord Injury. Stem Cell Rep, 2018; 11(6):1433–1448; doi: 10.1016/j.stemcr.2018.10.017.
53.
StraleyKS, Po FooCW, HeilshornSC. Biomaterial design strategies for the treatment of spinal cord injuries. J Neurotrauma, 2010; 27(1):1–19; doi: 10.1089/neu.2009.0948.
54.
KimKD, LeeKS, CoricD, et al.A study of probable benefit of a bioresorbable polymer scaffold for safety and neurological recovery in patients with complete thoracic spinal cord injury: 6-month results from the INSPIRE study. J Neurosurg Spine, 2021; 34(5):808–817; doi: 10.3171/2020.8.SPINE191507.
55.
GillML, GrahnPJ, CalvertJS, et al.Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia. Nat Med, 2018; 24(11):1677–1682; doi: 10.1038/s41591-018-0175-7.
56.
AngeliCA, BoakyeM, MortonRA, et al.Recovery of over-ground walking after chronic motor complete spinal cord injury. N Engl J Med, 2018; 379(13):1244–1250; doi: 10.1056/NEJMoa1803588.
57.
Peña PinoI, HooverC, VenkateshS, et al.Long-term spinal cord stimulation after chronic complete spinal cord injury enables volitional movement in the absence of stimulation. Front Syst Neurosci, 2020; 14:35; doi: 10.3389/fnsys.2020.00035.
58.
WagnerFB, MignardotJ-B, Le Goff-MignardotCG, et al.Targeted neurotechnology restores walking in humans with spinal cord injury. Nature, 2018; 563(7729):65–71; doi: 10.1038/s41586-018-0649-2.
59.
AjiboyeAB, WillettFR, YoungDR, et al.Restoration of reaching and grasping movements through brain-controlled muscle stimulation in a person with tetraplegia: a proof-of-concept demonstration. Lancet, 2017; 389(10081):1821–1830; doi: 10.1016/S0140-6736(17)30601-3.
60.
DonatiARC, ShokurS, MoryaE, et al.Long-term training with a brain-machine interface-based gait protocol induces partial neurological recovery in paraplegic patients. Sci Rep, 2016; 6(1):30383; doi: 10.1038/srep30383.
61.
JamesND, McMahonSB, Field-FoteEC, et al.Neuromodulation in the restoration of function after spinal cord injury. The Lancet Neurology, 2018; 17(10):905–917; doi: 10.1016/S1474-4422(18)30287-4.
62.
CapogrossoM, MilekovicT, BortonD, et al.A brain–spinal interface alleviating gait deficits after spinal cord injury in primates. Nature, 2016; 539(7628):284–288; doi: 10.1038/nature20118.
63.
SquairJW, BélangerLM, TsangA, et al.Empirical targets for acute hemodynamic management of individuals with spinal cord injury. Neurology, 2019; 93(12):e1205–e1211; doi: 10.1212/WNL.0000000000008125.
64.
PhangI, WerndleMC, SaadounS, et al.Expansion duroplasty improves intraspinal pressure, spinal cord perfusion pressure, and vascular pressure reactivity index in patients with traumatic spinal cord injury: injured spinal cord pressure evaluation study. J Neurotrauma, 2015; 32(12):865–874; doi: 10.1089/neu.2014.3668.
65.
van MiddendorpJJ, BarbagalloG, SchuetzM, et al.Design and rationale of a prospective, observational European multicenter study on the efficacy of acute surgical decompression after traumatic spinal cord injury: the SCI-POEM Study. Spinal Cord, 2012; 50(9):686–694; doi: 10.1038/sc.2012.34.
66.
JhaA, LammertseDP, CollJR, et al.Apolipoprotein E S4 allele and outcomes of traumatic spinal cord injury. J Spinal Cord Med, 2008; 31(2):171–176; doi: 10.1080/10790268.2008.11760708.
67.
HuangW, KabbaniN, BrannanTK, et al.Association of a functional polymorphism in the CHRFAM7A gene with inflammatory response mediators and neuropathic pain after spinal cord injury. J Neurotrauma, 2019; 36(21):3026–3033; doi: 10.1089/neu.2018.6200.
68.
LinM, HuangW, KabbaniN, et al.Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. PLoS One, 2021; 16(5):e0251110; doi: 10.1371/journal.pone.0251110.
69.
Vidal RodriguezS, Castillo AguilarI, Cuesta VillaL, et al.TRPA1 polymorphisms in chronic and complete spinal cord injury patients with neuropathic pain: a pilot study. Spinal Cord Ser Cases, 2017; 3:17089; doi: 10.1038/s41394-017-0004-0.
70.
LarsonJM, MichalskiJP, CollacottEA, et al.Increased Prevalence of HLA-B27 in Patients with Ectopic Ossification Following Traumatic Spinal Cord Injury. Rheumatol Rehabil, 1981; 20(4):193–197; doi: 10.1093/rheumatology/20.4.193.
71.
LaliberteAM, KaradimasSK, VidalPM, et al.Mir21 modulates inflammation and sensorimotor deficits in cervical myelopathy: data from humans and animal models. Brain Commun, 2021; 3(1):fcaa234; doi: 10.1093/braincomms/fcaa234.
72.
BhalalaOG, PanL, SahniV, et al.MicroRNA-21 Regulates astrocytic response following spinal cord injury. J Neurosci, 2012; 32(50):17935–17947; doi: 10.1523/JNEUROSCI.3860-12.2012.
73.
KwonBK, StreijgerF, FallahN, et al.Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury. J Neurotrauma, 2017; 34(3):567–580; doi: 10.1089/neu.2016.4435.
74.
AarabiB, SansurCA, IbrahimiDM, et al.Intramedullary lesion length on postoperative magnetic resonance imaging is a strong predictor of ASIA Impairment Scale grade conversion following decompressive surgery in cervical spinal cord injury. Neurosurgery, 2017; 80(4):610–620; doi: 10.1093/neuros/nyw053.
75.
AarabiB, SimardJM, KuferaJA, et al.Intramedullary lesion expansion on magnetic resonance imaging in patients with motor complete cervical spinal cord injury. J Neurosurg Spine, 2012; 17(3):243–250; doi: 10.3171/2012.6.SPINE12122.
76.
FreundP, SeifM, WeiskopfN, et al.MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol, 2019; 18(12):1123–1135; doi: 10.1016/S1474-4422(19)30138-3.
77.
DavidG, MohammadiS, MartinAR, et al.Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging. Nat Rev Neurol, 2019; 15(12):718–731; doi: 10.1038/s41582-019-0270-5.
78.
Rubin-AsherD, ZeiligG, RatnerA, et al.Risk Factors for Failure of Heparin Thromboprophylaxis in Patients with Acute Traumatic Spinal Cord Injury. Thromb Res, 2010; 125(6):501–504; doi: 10.1016/j.thromres.2009.09.012.
79.
ChioJCT, WangJ, SurendranV, et al.Delayed administration of high dose human immunoglobulin G enhances recovery after traumatic cervical spinal cord injury by modulation of neuroinflammation and protection of the blood spinal cord barrier. Neurobiol Dis, 2021; 148:105187; doi: 10.1016/j.nbd.2020.105187.
80.
SeabrookTJ, JiangL, MaierM, et al.Minocycline affects microglia activation, Aβ deposition, and behavior in APP-Tg mice. Glia, 2006; 53(7):776–782; doi: 10.1002/glia.20338.
81.
FreundP, SeifM, WeiskopfN, et al.MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol, 2019; 18(12):1123–1135; doi: 10.1016/S1474-4422(19)30138-3.
82.
DavidG, MohammadiS, MartinAR, et al.Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging. Nat Rev Neurol, 2019; 15(12):718–731; doi: 10.1038/s41582-019-0270-5.
83.
MiyanjiF, FurlanJC, AarabiB, et al.Acute cervical traumatic spinal cord injury: MR imaging findings correlated with neurologic outcome—prospective study with 100 consecutive patients. Radiology, 2007; 243(3):820–827; doi: 10.1148/radiol.2433060583.
84.
BoldinC, RaithJ, FankhauserF, et al.Predicting neurologic recovery in cervical spinal cord injury with postoperative MR imaging. Spine (Phila Pa 1976), 2006; 31(5):554–559; doi: 10.1097/01.brs.0000201274.59427.a4.
85.
AarabiB, SimardJM, KuferaJA, et al.Intramedullary lesion expansion on magnetic resonance imaging in patients with motor complete cervical spinal cord injury. J Neurosurg Spine, 2012; 17(3):243–250; doi: 10.3171/2012.6.SPINE12122.
86.
TalbottJF, WhetstoneWD, ReaddyWJ, et al.The brain and spinal injury center score: a novel, simple, and reproducible method for assessing the severity of acute cervical spinal cordinjury with axial T2-weighted MRI findings. J Neurosurg Spine, 2015; 23(4):495–504; doi: 10.3171/2015.1.SPINE141033.
87.
KukrejaS, Schwab J and FarhadiF. Impact of initial clinical and imaging parameters on long-term neurological outcomes in acute traumatic cervical spinal cord injury. Neurosurgery 2016; doi: 10.1227/01.neu.0000489737.31599.5b.
88.
AarabiB, OlexaJ, ChryssikosT, et al.Extent of spinal cord decompression in motor complete (American Spinal Injury Association Impairment Scale Grades A and B) traumatic spinal cord injury patients: post-operative magnetic resonance imaging analysis of standard operative approaches. J Neurotrauma, 2019; 36(6):862–876; doi: 10.1089/neu.2018.5834.
89.
AarabiB, Akhtar-DaneshN, SimardJM, et al.Efficacy of early (≤ 24 hours), late (25-72 hours), and delayed (>72 hours) surgery with magnetic resonance imaging-confirmed decompression in American Spinal Injury Association Impairment Scale grades C and D acute traumatic central cord syndrome caused by spinal stenosis. J Neurotrauma, 2021; 38(15):2073–2083; doi: 10.1089/neu.2021.0040.
90.
AarabiB, Akhtar-DaneshN, ChryssikosT, et al.Efficacy of ultra-early (< 12 h), early (12-24 h), and late (>24-138.5 h) surgery with magnetic resonance imaging-confirmed decompression in American Spinal Injury Association Impairment Scale grades A, B, and C cervical spinal cord injury. J Neurotrauma, 2020; 37(3):448–457; doi: 10.1089/neu.2019.6606.
91.
WaltersBC, HadleyMN, HurlbertRJ, et al.Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery, 2013; 60(CN_suppl_1):82–91; doi: 10.1227/01.neu.0000430319.32247.7f.
92.
ChioJCT, PunjaniN, HejratiN, et al.Extracellular matrix and oxidative stress following traumatic spinal cord injury: physiological and pathophysiological roles and opportunities for therapeutic intervention. ARS, 2022; 37(1–3):184–207; doi: 10.1089/ars.2021.0120.
93.
GaviriaM, PrivatA, d'ArbignyP, et al.Neuroprotective effects of a novel NMDA antagonist, gacyclidine, after experimental contusive spinal cord injury in adult rats. Brain Res, 2000; 874(2):200–209; doi: 10.1016/S0006-8993(00)02581-6.
94.
Dell'AnnoMT, WangX, OnoratiM, et al.Human neuroepithelial stem cell regional specificity enables spinal cord repair through a relay circuit. Nat Commun, 2018; 9(1):3419; doi: 10.1038/s41467-018-05844-8.
KajikawaK, ImaizumiK, ShinozakiM, et al.Cell therapy for spinal cord injury by using human IPSC-derived region-specific neural progenitor cells. Mol Brain, 2020; 13(1):120; doi: 10.1186/s13041-020-00662-w.
97.
TaoY and ZhangS-C. Neural subtype specification from human pluripotent stem cells. Cell Stem Cell, 2016; 19(5):573–586; doi: 10.1016/j.stem.2016.10.015.
98.
WuP, TarasenkoYI, GuY, et al.Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci, 2002; 5(12):1271–1278; doi: 10.1038/nn974.
99.
ZholudevaLV, IyerN, QiangL, et al.Transplantation of neural progenitors and V2a interneurons after spinal cord injury. J Neurotrauma, 2018; 35(24):2883–2903; doi: 10.1089/neu.2017.5439.
100.
DuncanGJ, ManeshSB, HiltonBJ, et al.Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination. Nat Commun, 2018; 9(1):3066; doi: 10.1038/s41467-018-05473-1.
101.
NagoshiN, KhazaeiM, AhlforsJ-E, et al.Human spinal oligodendrogenic neural progenitor cells promote functional recovery after spinal cord injury by axonal remyelination and tissue sparing. Stem Cell Transl Med, 2018; 7(11):806–818; doi: 10.1002/sctm.17-0269.
102.
HulmeCH, BrownSJ, FullerHR, et al.The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and nlood. Spinal Cord, 2017; 55(2):114–125; doi: 10.1038/sc.2016.174.
103.
van der WeijdenCWJ, GarcíaDV, BorraRJH, et al.Myelin quantification with MRI: a systematic review of accuracy and reproducibility. NeuroImage, 2021; 226:117561; doi: 10.1016/j.neuroimage.2020.117561.
104.
CapogrossoM, MilekovicT, BortonD, et al.A brain–spine interface alleviating gait deficits after spinal cord injury in primates. Nature, 2016; 539(7628):284–288; doi: 10.1038/nature20118.
105.
JajaBNR, BadhiwalaJ, GuestJ, et al. Trajectory-based classification of recovery in sensorimotor complete traumatic cervical spinal cord injury. Neurology 2021;10.1212/WNL.0000000000012028; doi: 10.1212/WNL.0000000000012028.
106.
WuX, LiuJ, TanadiniLG, et al.Challenges for defining minimal clinically important difference (MCID) after spinal cord injury. Spinal Cord, 2015; 53(2):84–91; doi: 10.1038/sc.2014.232.
107.
KhanO, BadhiwalaJH, WilsonJRF, et al.Predictive modeling of outcomes after traumatic and nontraumatic spinal cord injury using machine learning: review of current progress and future directions. Neurospine, 2019; 16(4):678–685; doi: 10.1424/5/ns.1938390.195.
108.
McCoyDB, DupontSM, GrosC, et al.Convolutional neural network–based automated segmentation of the spinal cord and contusion injury: deep learning biomarker correlates of motor impairment in acute spinal cord injury. Am J Neuroradiol, 2019; 40(4):737–744; doi: 10.3174/ajnr.A6020.
109.
FanG, YangS, LiuH, et al. Machine learning-based prediction of prolonged ICU-stay for critical patients with spinal cord injury. Spine 2021; doi: 10.1097/BRS.0000000000004267.
110.
FanG, LiuH, YangS, et al. Discharge prediction of critical patients with spinal cord injury: a machine learning study with 1485 cases. 2021; doi: 10.1101/2021.06.26.21259569.
111.
FallahN, NoonanVK, WaheedZ, et al. Development of a machine learning algorithm for predicting in-hospital and 1-year mortality after traumatic spinal cord injury. Spine J 2021; doi: 10.1016/j.spinee.2021.08.003.
112.
DeVriesZ, HodaM, RiversCS, et al.Development of an unsupervised machine learning algorithm for the prognostication of walking ability in spinal cord injury patients. Spine J, 2020; 20(2):213–224; doi: 10.1016/j.spinee.2019.09.007.